• Corpus ID: 83064467

The expression and regulation of membranetype matrix metalloproteinases (MT-MMPS) in prostate cancer

  title={The expression and regulation of membranetype matrix metalloproteinases (MT-MMPS) in prostate cancer},
  author={Tishila Palliyaguru},
Prostate cancer (PCa) represents the most frequently diagnosed cancer and the second leading cause of cancer death in males. Initial development and progression of the disease is mainly regulated by androgens. However, the pathology of the disease may progress to a loss of hormone dependence, resulting in rapid growth and a metastatic phenotype. Invasion and metastasis of tumour cells results from the degradation of the basement membrane (BM) and extracellular matrix (ECM). The… 

Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines

Investigation of the expression of MMPs and endogenous inhibitors in two parent epithelial prostate cancer cell lines and sublines of increasing invasive/metastatic potential found MMP-1, M MP-13 and TIMP-1 was higher in the more aggressive sublines and may be implicated in invasive/ metastatic ability.

Membrane-type metalloproteinases in tumor invasion.

[Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].

MT1-MMP protein and mRNA expression in human breast cancers had positive correlation with the stage, the tumor size and lymph node metastasis and can be a predictor for the ability of breast cancer invasion and metastasis.

Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients.

The results provide the first evidence of the expression of a MT-MMP in diabetes and suggest a novel role for MT5-M MP in the pathogenesis of renal tubular atrophy and end-stage renal disease.

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

The role of MMPs and their inhibitors in tumor invasion, angiogenesis and metastasis with special emphasis on the gelatinases, M MP-2 and MMP-9 are discussed.

Membrane type 1-matrix metalloproteinase (MT1-MMP) targeted antitumor agents

MT1-MMP is a therapeutic target in NSCLC and can be used to metabolise agents that are activated selectively by the tumour, with the peptide-conjugate displaying relative stability in plasma and normal tissues.

The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.

Stimulation of stromelysin-3 expression by TGF-beta in fibroblasts and osteoblasts could play a role in the metastasis of breast cancer cells and their homing and survival in bone.

Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Cell Invasion

MT1-MMP and its family may play a central role in the cell surface localization and activation of progelatinase A and via this mechanism, tumor cells use exogenous progelasinase A to mediate the proteolysis associated with invasion and metastasis.

Presence of high levels of MT1‐MMP protein in fibroblastic cells of human invasive carcinomas

MT1‐MMP protein was present in all invasive carcinomas tested, and it was almost exclusively located to the stromal cells and not to cancer cells as previously reported, suggesting that MMP2 activation might be a peri‐fibroblastic event.